An orally active Cannabis extract with high content in cannabidiol attenuates chemical induced intestinal inflammation and hypermotility in the mouse

• Main Authors: Ester Pagano (Author), Raffaele Capasso (Author), Fabiana Piscitelli (Author), Barbara Romano (Author), Olga Alessandra Parisi (Author), Stefania Finizio (Author), Anna Lauritano (Author), Vincenzo Di Marzo (Author), Angelo A Izzo (Author), Francesca Borrelli (Author)
• Format: Book
• Published: Frontiers Media S.A., 2016-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Anecdotal and scientific evidence suggests that Cannabis use may be beneficial in inflammatory bowel disease (IBD) patients. Here, we have investigated the effect of a standardized Cannabis sativa extract with high content of cannabidiol (CBD), here named CBD BDS for CBD botanical drug substance, on...